4 months ago
CRVO
AnalystsJason KolbertJason Kolbert's Stock Forecasts
AnalystsJason Kolbert
Analyst Ranking
Bottom 1%
#4925 out of 4930 analysts
Average Return
-7.98%
Win Rate
37%182 out of 487
Risk vs Reward
Poor
Good
Jason Kolbert's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Artelo Biosciences IncARTL | +199.66% | $5.31 | $15.90 | 2025-04-01 - 2025-07-08 | Strong Buy |
Nrx Pharmaceuticals IncNRXP | +184.03% | $1.19 | $3.38 | 2024-11-15 - 2025-07-08 | Strong Buy |
Cervomed IncCRVO | +174.13% | $2.30 | $6.31 | 2025-02-18 - 2025-07-08 | Strong Buy |
Nrx Pharmaceuticals IncNRXP | +172.58% | $1.24 | $3.38 | 2024-10-20 - 2025-07-08 | Strong Buy |
Cervomed IncCRVO | +167.16% | $2.36 | $6.31 | 2025-03-10 - 2025-07-08 | Strong Buy |
Jason Kolbert Analyst Color
Get additional color on Jason Kolbert's coverage of popular stocks
Jason Kolbert's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Immunitybio IncIBRX | 23 | Strong Buy | $30.00 | +1,007.01% | Maintains | a day ago |
Artelo Biosciences IncARTL | 9 | Strong Buy | $20.00 | +25.79% | Upgrades | a day ago |
Urogen Pharma LtdURGN | 18 | Strong Buy | $25.00 | +82.35% | Maintains | 2 days ago |
Os Therapies IncOSTX | 17 | Strong Buy | $20.00 | +1,134.57% | Maintains | 6 days ago |
Medicus Pharma LtdMDCX | 9 | Strong Buy | $27.00 | +698.82% | Maintains | 8 days ago |
Clene IncCLNN | 14 | Strong Buy | $23.00 | +505.26% | Maintains | 9 days ago |
Omeros CorpOMER | 9 | Strong Buy | $36.00 | +1,050.16% | Maintains | 9 days ago |
Citius Pharmaceuticals IncCTXR | 12 | Strong Buy | $6.00 | +210.08% | Maintains | 9 days ago |
Reviva Pharmaceuticals Holdings IncRVPH | 9 | Strong Buy | $3.00 | +689.47% | Maintains | 12 days ago |
Invivyd IncIVVD | 11 | Strong Buy | $9.00 | +1,148.27% | Maintains | 13 days ago |
Hoth Therapeutics IncHOTH | 13 | Strong Buy | $5.00 | +284.62% | Maintains | 13 days ago |
Cytosorbents CorpCTSO | 14 | Strong Buy | $10.00 | +852.38% | Maintains | 14 days ago |
Immunic IncIMUX | 13 | Strong Buy | $10.00 | +1,106.27% | Maintains | 14 days ago |
Plus Therapeutics IncPSTV | 4 | Hold | $9.00 | +2,627.27% | Maintains | 14 days ago |
Biomea Fusion IncBMEA | 16 | Strong Buy | $16.00 | +760.22% | Maintains | 15 days ago |
Cero Therapeutics Holdings IncCERO | 5 | Strong Buy | $30.00 | +246.02% | Maintains | 15 days ago |
Lineage Cell Therapeutics IncLCTX | 6 | Strong Buy | $2.00 | +104.08% | Maintains | 16 days ago |
Nrx Pharmaceuticals IncNRXP | 16 | Strong Buy | $31.00 | +817.16% | Maintains | 16 days ago |
Cormedix IncCRMD | 7 | Strong Buy | $15.00 | +32.98% | Maintains | 16 days ago |
Tevogen Bio Holdings IncTVGN | 8 | Strong Buy | $10.00 | +719.67% | Maintains | 21 days ago |
Fibrobiologics IncFBLG | 13 | Strong Buy | $16.00 | +2,544.63% | Maintains | 22 days ago |
Geovax Labs IncGOVX | 16 | Strong Buy | $9.00 | +1,288.89% | Maintains | 23 days ago |
Quince Therapeutics IncQNCX | 8 | Strong Buy | $4.00 | +148.45% | Maintains | a month ago |
Cervomed IncCRVO | 8 | Strong Buy | $10.00 | +58.60% | Maintains | a month ago |
Avita Medical IncRCEL | 9 | Strong Buy | $19.00 | +238.68% | Maintains | a month ago |
Anixa Biosciences IncANIX | 12 | Strong Buy | $10.00 | +218.47% | Maintains | a month ago |
Humacyte IncHUMA | 16 | Strong Buy | $25.00 | +872.76% | Maintains | a month ago |
Nano X Imaging LtdNNOX | 6 | Strong Buy | $10.00 | +91.20% | Maintains | a month ago |
Kairos Pharma LtdKAPA | 10 | Strong Buy | $9.00 | +1,255.42% | Maintains | a month ago |
Estrella Immunopharma IncESLA | 4 | Strong Buy | $16.00 | +1,736.97% | Maintains | a month ago |
Trevi Therapeutics IncTRVI | 14 | Strong Buy | $21.00 | +258.67% | Maintains | a month ago |
Collplant Biotechnologies LtdCLGN | 8 | Strong Buy | $12.00 | +757.14% | Maintains | a month ago |
Imunon IncIMNN | 12 | Strong Buy | $17.00 | +2,231.96% | Maintains | 2 months ago |
Context Therapeutics IncCNTX | 6 | Strong Buy | $9.00 | +1,299.69% | Maintains | 2 months ago |
Pulmonx CorpLUNG | 3 | Strong Buy | $17.00 | +522.71% | Maintains | 2 months ago |
Volitionrx LtdVNRX | 13 | Strong Buy | $5.00 | +604.23% | Maintains | 2 months ago |
Compass Therapeutics IncCMPX | 7 | Strong Buy | $32.00 | +1,107.55% | Maintains | 2 months ago |
Co Diagnostics IncCODX | 1 | Strong Buy | $10.00 | +3,471.43% | Initiates Coverage On | 2 months ago |
Coya Therapeutics IncCOYA | 9 | Strong Buy | $18.00 | +200.00% | Maintains | 2 months ago |
Enlivex Therapeutics LtdENLV | 10 | Strong Buy | $13.00 | +1,001.69% | Maintains | 3 months ago |
Can Fite Biopharma LtdCANF | 12 | Strong Buy | $10.00 | +870.87% | Maintains | 3 months ago |
Medicinova IncMNOV | 5 | Strong Buy | $9.00 | +620.00% | Maintains | 3 months ago |
Anavex Life Sciences CorpAVXL | 11 | Strong Buy | $46.00 | +351.42% | Maintains | 3 months ago |
Scilex Holding CoSCLX | 3 | Strong Buy | $630.00 | +9,852.61% | Maintains | 3 months ago |
Carisma Therapeutics IncCARM | 9 | Strong Buy | $1.00 | +148.76% | Maintains | 3 months ago |
Checkpoint Therapeutics IncCKPT | 3 | Strong Buy | $4.80 | +12.68% | Maintains | 3 months ago |
Marinus Pharmaceuticals IncMRNS | 5 | Strong Buy | $3.00 | +445.45% | Maintains | 8 months ago |
Annovis Bio IncANVS | 4 | Strong Buy | $21.00 | +730.04% | Maintains | 8 months ago |
Lumos Pharma IncLUMO | 1 | Strong Buy | $16.00 | +268.66% | Initiates Coverage On | 9 months ago |
Tonix Pharmaceuticals Holding CorpTNXP | 1 | Strong Buy | $9,600.00 | N/A | Initiates Coverage On | a year ago |
Cemtrex IncCETX | 1 | Strong Buy | $45,990.00 | N/A | Maintains | 2 years ago |
Genprex IncGNPX | 1 | Strong Buy | $120.00 | N/A | Initiates Coverage On | 2 years ago |
Zomedica CorpZOMDF | 1 | Strong Buy | $6.00 | N/A | Initiates Coverage On | 3 years ago |
Biocardia IncBCDA | 1 | Hold | N/A | N/A | Downgrades | 3 years ago |
Aditxt IncADTX | 1 | Hold | N/A | N/A | Downgrades | 3 years ago |
Smart For Life IncSMFL | 1 | Strong Buy | $25,200.00 | N/A | Initiates Coverage On | 3 years ago |
Dyadic International IncDYAI | 1 | Hold | N/A | N/A | Downgrades | 3 years ago |
Know Labs IncKNW | 1 | Strong Buy | $7.00 | N/A | Initiates Coverage On | 3 years ago |
Alarum Technologies LtdALAR | 1 | Strong Buy | $6.00 | N/A | Initiates Coverage On | 3 years ago |
Bluejay Diagnostics IncBJDX | 1 | Strong Buy | $80,000.00 | N/A | Initiates Coverage On | 3 years ago |
Prophase Labs IncPRPH | 1 | Hold | N/A | N/A | Downgrades | 4 years ago |
Check Cap LtdCHEK | 1 | Hold | $40.00 | N/A | Downgrades | 4 years ago |
Soligenix IncSNGX | 2 | Hold | $480.00 | N/A | Downgrades | 5 years ago |
Oncosec Medical IncONCSQ | 1 | Strong Buy | $220.00 | N/A | Initiates Coverage On | 5 years ago |
Sorrento Therapeutics IncSRNEQ | 1 | Strong Buy | $24.00 | N/A | Initiates Coverage On | 5 years ago |
Imac Holdings IncBACK | 1 | Hold | N/A | N/A | Downgrades | 5 years ago |
Coherus Biosciences IncCHRS | 3 | Buy | $28.00 | N/A | Initiates Coverage On | 7 years ago |
Indaptus Therapeutics IncINDP | 1 | Strong Buy | $8.00 | N/A | Maintains | 8 years ago |
Sonoma Pharmaceuticals IncSNOA | 1 | Strong Buy | $1,980.00 | N/A | Maintains | 8 years ago |
Mannkind CorpMNKD | 1 | Hold | N/A | N/A | Downgrades | 8 years ago |
Brainstorm Cell Therapeutics IncBCLI | 1 | Strong Buy | $135.00 | N/A | Maintains | 8 years ago |
Interpace Biosciences IncIDXG | 1 | Strong Buy | $50.00 | N/A | Initiates Coverage On | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.